Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. Visit www.agios.com to learn more
Please make sure the password is typed in ALL CAPS and includes the exclamation point. Enter the email address that you used to register for the conference.